News
AstraZeneca PLC closed 23.78% short of its 52-week high of £133.88, which the company achieved on September 3rd.
Summit Therapeutics and AstraZeneca are discussing a partnership deal worth as much as $15 billion, Bloomberg News reported ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback